ThermoGenesis Announces That Results of ImmuneCyte's Licensed Neutralizing Antibody Therapeutics for COVID-19 Were Published in bioRxiv

Stock Information for ThermoGenesis Holdings Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About ThermoGenesis Holdings Inc.

ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update
ThermoGenesis to Open a New 35,500 Square Foot ReadyStart-IncuStart cGMP Facility in Greater Sacramento
ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference
ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate Update
ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update
ThermoGenesis Expands Board of Directors with the Appointments of Dr. Biao Xi and Dr. James Xu
ThermoGenesis Holdings Announces First Quarter 2023 Financial Results and Provides Corporate Update
ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide a Corporate Strategic Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.